XML 36 R19.htm IDEA: XBRL DOCUMENT v3.20.4
Fair Value
12 Months Ended
Dec. 31, 2020
Fair Value [Abstract]  
Fair Value
10.
Fair Value

The carrying value of financial instruments including cash and cash equivalents, accounts receivable and accounts payable approximate fair values due to the short-term nature of these instruments. Fair value estimates are made at a specific point in time, based on relevant market information.

The following tables present the fair value hierarchy for those assets and liabilities measured at fair value on a recurring basis (U.S. dollars in thousands):

 
Fair Value at December 31, 2020
 
   
Level 1
   
Level 2
   
Level 3
   
Total
 
Financial assets (liabilities):
                       
Cash equivalents and current investments
 
$
56,628
   
$
   
$
   
$
56,628
 
Derivative financial instruments asset
   
     
1,145
     
     
1,145
 
Life insurance contracts
   
     
     
45,453
     
45,453
 
Derivative financial instruments liability
   
     
(105
)
   
     
(105
)
Contingent consideration
   
     
     
(3,125
)
   
(3,125
)
Total
 
$
56,628
   
$
1,040
   
$
42,328
   
$
99,996
 

 
Fair Value at December 31, 2019
 
   
Level 1
   
Level 2
   
Level 3
   
Total
 
Financial assets:
                       
Cash equivalents and current investments
 
$
54,642
   
$
   
$
   
$
54,642
 
Other long-term assets
   
3,216
     
     
     
3,216
 
Life insurance contracts
   
     
     
41,707
     
41,707
 
Total
 
$
57,858
   
$
   
$
41,707
   
$
99,565
 

The following methods and assumptions were used to determine the fair value of each class of assets and liabilities recorded at fair value in the consolidated balance sheets:

Cash equivalents and current investments: Cash equivalents and current investments primarily consist of highly rated money market funds with maturities of three months or less, and are purchased daily at par value with specified yield rates. Due to the high ratings and short-term nature of the funds, the Company considers all cash equivalents and current investments as Level 1. Current investments include $21.2 million and $8.4 million as of December 31, 2020 and 2019, respectively, that is restricted for the Company’s voluntary participation in a consumer protection cooperative in South Korea, along with investments in corporate securities.

Life insurance contracts: ASC 820 preserves practicability exceptions to fair value measurements provided by other applicable provisions of U.S. GAAP. The guidance in ASC 715-30-35-60 allows a reporting entity, as a practical expedient, to use cash surrender value or conversion value as an expedient for fair value when it is present. Accordingly, the Company determines the fair value of its life insurance contracts as the cash-surrender value of life insurance policies held in its Rabbi Trust as disclosed in Note 13, “Executive Deferred Compensation Plan.”

Derivative financial instruments asset and liability: Derivative financial instruments are measured at fair value based on observable market information and appropriate valuation methods.  See Note 14 – Derivative Financial Instruments for more information on derivative financial instruments.

Contingent consideration: Contingent consideration represents the obligations incurred in connection with acquisitions. The estimate of fair value of the contingent consideration obligations requires subjective assumptions to be made regarding the future business results, discount rates, discount periods and probabilities assigned to various potential business result scenarios and was determined using probability assessments with respect to the likelihood of reaching various targets or of achieving certain milestones. The fair value measurement is based on significant inputs unobservable in the market and thus represents a level 3 measurement. Changes in current expectations of progress could change the probability of achieving the targets within the measurement periods and result in an increase or decrease in the fair value of the contingent consideration obligation.

The following table provides a summary of changes in fair value of the Company’s Level 3 marketable securities (U.S. dollars in thousands):

Life Insurance Contracts
 
2020
   
2019
 
Beginning balance at January 1
 
$
41,707
   
$
35,590
 
Actual return on plan assets
   
3,746
     
5,688
 
Purchases and issuances
   
     
2,003
 
Sales and settlements
   
     
(1,574
)
Transfers into Level 3
   
     
 
Ending balance at December 31
 
$
45,453
   
$
41,707